Experts to Collaborate on Improved Hepatitis C Patient Management
According to Health Canal, experts from the American Association for the Study of Liver Disease (AASLD) and the Infectious Disease Society of America (IDSA) are working to develop new practice recommendations for the management of hepatitis C and hepatitis C patients.
Better Patient Management Needed with Improvement Treatments and Screenings
- In light of recent advancements and with new hepatitis C medications currently in development including Daclastavir and Sofosbuvir, experts are hopeful that a true hepatitis C cure may finally be a possibility.
- Physicians are so hopeful that better treatments are right around the corner that some doctors are recommending patients wait for the next hepatitis C breakthrough instead of undergoing what is currently a very long and very expensive course of treatement which only carries a 43 percent success rate.
- Also, new hepatitis C screening guidelines are expected to result in a spike in the number of diagnosed patients as many of those infected with hepatitis C are not aware they are even infected.
- With all this in mind, the concern that the AASLD and IDSA have now is how the medical community will manage what is likely to be unprecedented levels of hepatitis C patients seeking treatment.
- The two organizations are now collaborating with a goal of creating new management recommendations which use a fluid management system that is capable of being regularly updated and made available to both patients and physicians online in efforts to deal with increased treatment demands.
About Hepatitis C and Hepatitis C Diagnosis
- Hepatitis C is a chronic liver inflammation which result in the swelling and inflammation of the liver which can result in liver failure and death.
- It is currently estimated that up to 4 million Americans have been infected with the hepatitis C virus and suffer from liver disease as a result.
- Even more alarming is that 70 percent of these 4 million Americans do not even know that they are infected as liver disease often lacks clear symptoms in early stages.
- A study by the Journal of The American Medical Association has found that the number of deaths linked to hepatitis C has been on the rise since 1990 and has become the most likely cause of liver transplant.
Contact an Experienced Drug Trial Injury Attorney
If you or a loved one participated in a Hepatitis C clinical trial and suffered injuries, contact Thomas J. Henry immediately for a free consultation. We are available 24/7 nights and weekends. Call 1-888-956-8000.